BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16766265)

  • 1. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity.
    Fedele M; Visone R; De Martino I; Troncone G; Palmieri D; Battista S; Ciarmiello A; Pallante P; Arra C; Melillo RM; Helin K; Croce CM; Fusco A
    Cancer Cell; 2006 Jun; 9(6):459-71. PubMed ID: 16766265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of the HMGA2 gene in pituitary adenomas.
    Fedele M; Pierantoni GM; Visone R; Fusco A
    Cell Cycle; 2006 Sep; 5(18):2045-8. PubMed ID: 16969098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-mobility group A2 gene expression is frequently induced in non-functioning pituitary adenomas (NFPAs), even in the absence of chromosome 12 polysomy.
    Pierantoni GM; Finelli P; Valtorta E; Giardino D; Rodeschini O; Esposito F; Losa M; Fusco A; Larizza L
    Endocr Relat Cancer; 2005 Dec; 12(4):867-74. PubMed ID: 16322327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis.
    Palmieri D; D'Angelo D; Valentino T; De Martino I; Ferraro A; Wierinckx A; Fedele M; Trouillas J; Fusco A
    Oncogene; 2012 Aug; 31(34):3857-65. PubMed ID: 22139073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas.
    Finelli P; Pierantoni GM; Giardino D; Losa M; Rodeschini O; Fedele M; Valtorta E; Mortini P; Croce CM; Larizza L; Fusco A
    Cancer Res; 2002 Apr; 62(8):2398-405. PubMed ID: 11956103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
    De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
    Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors.
    Olson MV; Johnson DG; Jiang H; Xu J; Alonso MM; Aldape KD; Fuller GN; Bekele BN; Yung WK; Gomez-Manzano C; Fueyo J
    Cancer Res; 2007 May; 67(9):4005-9. PubMed ID: 17483310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis.
    Palmieri D; Valentino T; De Martino I; Esposito F; Cappabianca P; Wierinckx A; Vitiello M; Lombardi G; Colao A; Trouillas J; Pierantoni GM; Fusco A; Fedele M
    Endocr Relat Cancer; 2012 Apr; 19(2):123-35. PubMed ID: 22199144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice.
    Lin HH; Xiong Y; Ho YS; Zhou B; Nguyen HV; Deng H; Lee R; Yen Y; Borok Z; Ann DK
    Eur J Oral Sci; 2007 Feb; 115(1):30-9. PubMed ID: 17305714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGA2: A pituitary tumour subtype-specific oncogene?
    Fedele M; Palmieri D; Fusco A
    Mol Cell Endocrinol; 2010 Sep; 326(1-2):19-24. PubMed ID: 20347930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misexpression of full-length HMGA2 induces benign mesenchymal tumors in mice.
    Zaidi MR; Okada Y; Chada KK
    Cancer Res; 2006 Aug; 66(15):7453-9. PubMed ID: 16885341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGA2 cooperates with either p27
    Fedele M; Paciello O; De Biase D; Monaco M; Chiappetta G; Vitiello M; Barbieri A; Rea D; Luciano A; Papparella S; Arra C; Fusco A
    Cell Cycle; 2018; 17(5):580-588. PubMed ID: 29157111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1.
    D'Angelo D; Palmieri D; Mussnich P; Roche M; Wierinckx A; Raverot G; Fedele M; Croce CM; Trouillas J; Fusco A
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1128-38. PubMed ID: 22564666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation.
    Ying L; Marino J; Hussain SP; Khan MA; You S; Hofseth AB; Trivers GE; Dixon DA; Harris CC; Hofseth LJ
    Cancer Res; 2005 Oct; 65(20):9132-6. PubMed ID: 16230367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1 activation is responsible for pituitary adenomas induced by HMGA2 gene overexpression.
    Fedele M; Pierantoni GM; Visone R; Fusco A
    Cell Div; 2006 Aug; 1():17. PubMed ID: 16914062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dissection of the architectural transcription factor HMGA2.
    Noro B; Licheri B; Sgarra R; Rustighi A; Tessari MA; Chau KY; Ono SJ; Giancotti V; Manfioletti G
    Biochemistry; 2003 Apr; 42(15):4569-77. PubMed ID: 12693954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-like elements in p27(Kip1) promoter specifically sense deregulated E2F activity.
    Ozono E; Komori H; Iwanaga R; Ikeda MA; Iseki S; Ohtani K
    Genes Cells; 2009 Jan; 14(1):89-99. PubMed ID: 19077036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas.
    Fedele M; Battista S; Kenyon L; Baldassarre G; Fidanza V; Klein-Szanto AJ; Parlow AF; Visone R; Pierantoni GM; Outwater E; Santoro M; Croce CM; Fusco A
    Oncogene; 2002 May; 21(20):3190-8. PubMed ID: 12082634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional E2F1 activation in transgenic mice causes testicular atrophy and dysplasia mimicking human CIS.
    Agger K; Santoni-Rugiu E; Holmberg C; Karlström O; Helin K
    Oncogene; 2005 Jan; 24(5):780-9. PubMed ID: 15531911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.